Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J H Porter

Showing results (141-150 of 232) with videos related to

Pageof 24
Sort By:
Pharmaceutical Research|July 22, 2006
An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to ratsNatalie L Trevaskis, Chun Min Lo, Li Yun Ma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2011
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linkerLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Molecular Pharmaceutics|December 22, 2010
Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Molecular Pharmaceutics|October 24, 2007
Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and dispositionLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
Journal of Pharmaceutical Sciences|December 8, 2007
Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogsJean F Cuiné, Claire L McEvoy, William N Charman, et al.
Molecular Pharmaceutics|May 21, 2009
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Journal of Pharmaceutical Sciences|April 7, 2004
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrineChristopher J H Porter, Ann Marie Kaukonen, Agnes Taillardat-Bertschinger, et al.
Pharmaceutical Research|March 12, 2010
The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623)Natalie L Trevaskis, Claire L McEvoy, Michelle P McIntosh, et al.
Molecular Pharmaceutics|April 24, 2015
Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulationsYasemin Sahbaz, Hywel D Williams, Tri-Hung Nguyen, et al.
Molecular Pharmaceutics|October 28, 2017
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623Claire L McEvoy, Natalie L Trevaskis, Orlagh M Feeney, et al.
Pageof 24

Showing results (141-150 of 232) with videos related to

Sort By:
Pageof 24
Pharmaceutical Research|July 22, 2006
An acute and coincident increase in FABP expression and lymphatic lipid and drug transport occurs during intestinal infusion of lipid-based drug formulations to ratsNatalie L Trevaskis, Chun Min Lo, Li Yun Ma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 15, 2011
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linkerLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Molecular Pharmaceutics|December 22, 2010
Capping methotrexate α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Molecular Pharmaceutics|October 24, 2007
Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and dispositionLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
Journal of Pharmaceutical Sciences|December 8, 2007
Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogsJean F Cuiné, Claire L McEvoy, William N Charman, et al.
Molecular Pharmaceutics|May 21, 2009
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimersLisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Journal of Pharmaceutical Sciences|April 7, 2004
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrineChristopher J H Porter, Ann Marie Kaukonen, Agnes Taillardat-Bertschinger, et al.
Pharmaceutical Research|March 12, 2010
The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623)Natalie L Trevaskis, Claire L McEvoy, Michelle P McIntosh, et al.
Molecular Pharmaceutics|April 24, 2015
Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulationsYasemin Sahbaz, Hywel D Williams, Tri-Hung Nguyen, et al.
Molecular Pharmaceutics|October 28, 2017
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623Claire L McEvoy, Natalie L Trevaskis, Orlagh M Feeney, et al.
Pageof 24